Hormones and Agents Affecting Hormonal Mechanism: Calcium Regulating Agents
OREGP1 “Regpara tablet” 25 mg/tab
適應症：治療透析患者的次發性副甲狀腺機能亢進。
Usual dose:
Adult: 30mg qd; titrate as necessary no more frequently than q2-4wks through sequential doses of 60 mg, 90 mg, 120 mg, and 180 mg qd.
Precaution: Do not initiate if serum calcium levels are below the lower limit of normal.
Adverse effect:
Common: hypertension, hypercalcemia, abdominal pain, diarrhea, loss of appetite, parathyroid carcinoma, nausea, vomiting, anemia, arthralgia, myalgia, spasm, asthenia, depression, cough, dyspnea, URI, fatigue.
Serious: QTc prolong, ventricular arrhythmia, hypocalcemia, hypersensitivity reaction, seizure.
Related Entries
(Visited 53 times, 1 visits today)